This dual regulatory effect leads to significant inhibition of prostate cancer cell proliferation, invasion, and clonogenic ability, whereas overexpression of WIP1 reverses the anticancer effects of miR-145-5p, confirming that WIP1 is a core effector molecule in this pathway (Sun et al., 2021). The gene discussed is PPM1D; the disease is prostate cancer.